Prescribed dietary phosphate restriction and survival among hemodialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 3, 2011, Pages 620-629

  Lynch, Katherine E ^a,b   Lynch, Rebecca ^c   Curhan, Gary C ^b,c   Brunelli, Steven M ^b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATE; VITAMIN D;

ADULT; ARTICLE; CALORIC INTAKE; DIET RESTRICTION; FEMALE; HAZARD RATIO; HEMODIALYSIS; HUMAN; HYPERPHOSPHATEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; POST HOC ANALYSIS; PRESCRIPTION; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TIME;

AGED; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYPERPHOSPHATEMIA; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PHOSPHATES; PHOSPHORUS, DIETARY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 79952999412     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04620510     Document Type: Article

References (50)

1. Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, Young EW, Akizawa T, Akiba T, Pisoni RL, Robinson BM, Port FK: Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 52: 519-530, 2008
2. Kimata N, Albert JM, Akiba T, Yamazaki S, Kawaguchi T, Fukuhara S, Akizawa T, Saito A, Asano Y, Kurokawa K, Pisoni RL, Port FK: Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: The Japan dialysis outcomes and practice patterns study. Hemodial Int 11: 340-348, 2007 (Pubitemid 46958589)
3. Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK: Predictors and consequences of altered mineral metabolism: The dialysis outcomes and practice patterns study. Kidney Int 67: 1179-1187, 2005 (Pubitemid 41623345)
4. Slinin Y, Foley RN, Collins AJ: Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: The USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 16: 1788-1793, 2005 (Pubitemid 41716485)
5. Port FK, Pisoni RL, Bommer J, Locatelli F, Jadoul M, Eknoyan G, Kurokawa K, Canaud BJ, Finley MP, Young EW: Improving outcomes for dialysis patients in the international dialysis outcomes and practice patterns study. Clin J Am Soc Nephrol 1: 246-255, 2006
6. Pires A, Adragão T, Pais MJ, Vinhas J, Ferreira HG: Inferring disease mechanisms from epidemiological data in chronic kidney disease: Calcium and phosphorus metabolism. Nephron Clinical Practice 112: c137-c147, 2009
7. Slatopolsky E, Brown A, Dusso A: Role of phosphorus in the pathogenesis of secondary hyperparathyroidism. Am J Kidney Dis 37[Suppl 2]: S54-S57, 2001 (Pubitemid 32048024)
8. Imanishi Y, Inaba M, Nakatsuka K, Nagasue K, Okuno S, Yoshihara A, Miura M, Miyauchi A, Kobayashi K, Miki T, Shoji T, Ishimura E, Nishizawa Y: FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int 65: 1943-1946, 2004
9. Gupta A, Winer K, Econs MJ, Marx SJ, Collins MT: FGF-23 is elevated by chronic hyperphosphatemia. J Clin Endocrinol Metab 89: 4489-4492, 2004 (Pubitemid 39244460)
10. Lezaic V, Tirmenstajn-Jankovic B, Bukvic D, Vujisic B, Perovic M, Novakovic N, Dopsaj V, Maric I, Djukanovic L: Efficacy of hyperphosphatemia control in the progression of chronic renal failure and the prevalence of cardiovascular calcification. Clin Nephrol 71: 21-29, 2009
11. Cozzolino M, Brancaccio D, Gallieni M, Slatopolsky E: Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int 68: 429-436, 2005 (Pubitemid 43323098)
12. Roman-Garcia P, Carrillo-Lopez N, Fernandez-Martin JL, Naves-Diaz M, Ruiz-Torres MP, Cannata-Andia JB: High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression. Bone 46: 121-128, 2010
13. Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Juppner H, Wolf M: Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359: 584-592, 2008
14. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004 (Pubitemid 39031360)
15. Rennenberg RJ, Kessels AG, Schurgers LJ, van Engelshoven JM, de Leeuw PW, Kroon AA: Vascular calcifications as a marker of increased cardiovascular risk: A meta-analysis. Vasc Health Risk Manag 5: 185-197, 2009
16. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 31: 607-617, 1998
17. Noordzij M, Korevaar JC, Dekker FW, Boeschoten EW, Bos WJ, Krediet RT, Bossuyt PM, Geskus RB, NECOSAD study group: Mineral metabolism and mortality in dialysis patients: A reassessment of the K/DOQI guideline. Blood Purif 26: 231-237, 2008 (Pubitemid 351748055)
18. Wald R, Sarnak MJ, Tighiouart H, Cheung AK, Levey AS, Eknoyan G, Miskulin DC: Disordered mineral metabolism in hemodialysis patients: An analysis of cumulative effects in the hemodialysis (HEMO) study. Am J Kidney Dis 52: 531-540, 2008
19. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113: S1-S130, 2009
20. Sullivan C, Sayre SS, Leon JB, Machekano R, Love TE, Porter D, Marbury M, Sehgal AR: Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: A randomized controlled trial. JAMA 301: 629-635, 2009
21. Ford JC, Pope JF, Hunt AE, Gerald B: The effect of diet education on the laboratory values and knowledge of hemodialysis patients with hyperphosphatemia. J Ren Nutr 14: 36-44, 2004 (Pubitemid 38121616)
22. Cupisti A, D'Alessandro C, Baldi R, Barsotti G: Dietary habits and counseling focused on phosphate intake in hemodialysis patients with hyperphosphatemia. J Ren Nutr 14: 220-225, 2004 (Pubitemid 39360978)
23. Combe C, Aparicio M: Phosphorus and protein restriction and parathyroid function in chronic renal failure. Kidney Int 46: 1381-1386, 1994 (Pubitemid 24330717)
24. Williams PS, Stevens ME, Fass G, Irons L, Bone JM: Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: A prospective, randomized, controlled trial. Q J Med 81: 837-855, 1991
25. Sherman RA, Mehta O: Dietary phosphorus restriction in dialysis patients: Potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis 54: 18-23, 2009
26. Uribarri J: Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial 20: 295-301, 2007
27. Ikizler TA: Dietary protein restriction in CKD: The debate continues. Am J Kidney Dis 53: 189-191, 2009
28. Mehrotra R, Nolph KD: Low protein diets are not needed in chronic renal failure. Miner Electrolyte Metab 25: 311-316, 1999 (Pubitemid 30099683)
29. Rufino M, de Bonis E, Martin M, Rebollo S, Martin B, Miquel R, Cobo M, Hernandez D, Torres A, Lorenzo V: Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition? Nephrol Dial Transplant 13[Suppl 3]: 65-67, 1998 (Pubitemid 28154347)
30. Coladonato JA: Control of hyperphosphatemia among patients with ESRD. J Am Soc Nephrol 16[Suppl 2]: S107-S114, 2005
31. Kalantar-Zadeh K, Supasyndh O, Lehn RS, McAllister CJ, Kopple JD: Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20. J Ren Nutr 13: 15-25, 2003 (Pubitemid 38388175)
32. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 38: 1251-1263, 2001 (Pubitemid 34193111)
33. Lacson E Jr, Ikizler TA, Lazarus JM, Teng M, Hakim RM: Potential impact of nutritional intervention on end-stage renal disease hospitalization, death, and treatment costs. J Ren Nutr 17: 363-371, 2007 (Pubitemid 47633465)
34. Pupim LB, Caglar K, Hakim RM, Shyr Y, Ikizler TA: Uremic malnutrition is a predictor of death independent of inflammatory status. Kidney Int 66: 2054-2060, 2004
35. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R, Hemodialysis (HEMO) Study Group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
36. Greene T, Beck GJ, Gassman JJ, Gotch FA, Kusek JW, Levey AS, Levin NW, Schulman G, Eknoyan G: Design and statistical issues of the hemodialysis (HEMO) study. Control Clin Trials 21: 502-525, 2000
37. Daugirdas JT: Estimation of equilibrated Kt/V using the unequilibrated post dialysis BUN. Semin Dial 8: 283-284, 1995
38. National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42[Suppl 3]: S1-S201, 2003
39. Blumenkrantz MJ, Kopple JD, Gutman RA, Chan YK, Barbour GL, Roberts C, Shen FH, Gandhi VC, Tucker CT, Curtis FK, Coburn JW: Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr 33: 1567-1585, 1980 (Pubitemid 10013705)
40. Lightfoot BO, Caruana RJ, Mulloy LL, Fincher ME: Simple formula for calculating normalized protein catabolic rate (NPCR) in hemodialysis (HD) patients (abstract). J Am Soc Nephrol 4: 363, 1993
41. Cole SR, Hernan MA: Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed 75: 45-49, 2004 (Pubitemid 38648876)
42. Robins JM, Hernan MA, Brumback B: Marginal structural models and causal inference in epidemiology. Epidemiology 11: 550-560, 2000 (Pubitemid 30660034)
43. Hernan MA, Brumback B, Robins JM: Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 11: 561-570, 2000 (Pubitemid 30660035)
44. Brunelli SM, Joffe MM, Israni RK, Yang W, Fishbane S, Berns JS, Feldman HI: History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients. Clin J Am Soc Nephrol 3: 777-782, 2008
45. Brunelli SM, Chertow GM, Ankers ED, Lowrie EG, Thadhani R: Shorter dialysis times are associated with higher mortality among incident hemodialysis patients. Kidney Int 77: 630-636, 2010
46. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA Jr, Thadhani R: Activated injectable vitamin D and hemodialysis survival: A historical cohort study. J Am Soc Nephrol 16: 1115-1125, 2005 (Pubitemid 41710323)
47. Sherman RA: Dietary phosphate restriction and protein intake in dialysis patients: A misdirected focus. Semin Dial 20: 16-18, 2007
48. Cupisti A, Morelli E, D'Alessandro C, Lupetti S, Barsotti G: Phosphate control in chronic uremia: Don't forget diet. J Nephrol 16: 29-33, 2003
49. Isakova T, Gutierrez OM, Chang Y, Shah A, Tamez H, Smith K, Thadhani R, Wolf M: Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol 20: 388-396, 2009
50. Manley HJ, Garvin CG, Drayer DK, Reid GM, Bender WL, Neufeld TK, Hebbar S, Muther RS: Medication prescribing patterns in ambulatory haemodialysis patients: Comparisons of USRDS to a large not-for-profit dialysis provider. Nephrol Dial Transplant 19: 1842-1848, 2004